One-point versus three-point botulinum toxin type A injection for masseter reduction: a randomized controlled trial in a Thai population

Botulinum toxin type A injection is widely used for lower facial contouring, particularly in Asian populations. However, there is no consensus regarding the optimal injection technique. While multi-point injection is often advocated to enhance toxin distribution, single-point injection is favored for its procedural simplicity. This study aimed to compare the longitudinal effects of one-point and three-point injection techniques on lower facial volume reduction and patient satisfaction. This triple-blind randomized controlled trial included 24 participants, randomly assigned to one-point or three-point injection groups. All participants received 25 U of prabotulinumtoxinA (Nabota ® ) per side of the masseter muscle. Lower facial volume was assessed using three-dimensional facial scanning, and patient satisfaction was evaluated using the FACE-Q™ questionnaire at baseline and at 1, 2, 3, and 6 months post-injection. Longitudinal changes were analyzed using linear mixed-effects models. Significant time-dependent changes were observed in both lower facial volume reduction and patient satisfaction ( p < 0.001). No significant technique-by-time interaction was detected for either outcome, providing no evidence of differences in the longitudinal response patterns between the two injection techniques. Both one-point and three-point injection techniques were associated with longitudinal changes in lower facial volume and patient satisfaction. No statistically significant differences in longitudinal response patterns were detected between the two techniques. The one-point technique may represent a simpler injection approach worthy of further investigation. Thai Clinical Trials Registry: TCTR20251016020 (registered October 16, 2025).

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-19
DOI
https://doi.org/10.1038/s41598-026-79798-z
Primary Topic
Botulinum Toxin and Related Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

One-point versus three-point botulinum toxin type A injection for masseter reduction: a randomized controlled trial in a Thai population

Kanin Arunakul, Chanita Tantipoj, Eku Khwanngam
Scientific Reports
Botulinum Toxin and Related Neurological Disorders
article

One-point versus three-point botulinum toxin type A injection for masseter reduction: a randomized controlled trial in a Thai population

Kanin Arunakul, Chanita Tantipoj, Eku Khwanngam
article en

Abstract

Botulinum toxin type A injection is widely used for lower facial contouring, particularly in Asian populations. However, there is no consensus regarding the optimal injection technique. While multi-point injection is often advocated to enhance toxin distribution, single-point injection is favored for its procedural simplicity. This study aimed to compare the longitudinal effects of one-point and three-point injection techniques on lower facial volume reduction and patient satisfaction. This triple-blind randomized controlled trial included 24 participants, randomly assigned to one-point or three-point injection groups. All participants received 25 U of prabotulinumtoxinA (Nabota ® ) per side of the masseter muscle. Lower facial volume was assessed using three-dimensional facial scanning, and patient satisfaction was evaluated using the FACE-Q™ questionnaire at baseline and at 1, 2, 3, and 6 months post-injection. Longitudinal changes were analyzed using linear mixed-effects models. Significant time-dependent changes were observed in both lower facial volume reduction and patient satisfaction ( p < 0.001). No significant technique-by-time interaction was detected for either outcome, providing no evidence of differences in the longitudinal response patterns between the two injection techniques. Both one-point and three-point injection techniques were associated with longitudinal changes in lower facial volume and patient satisfaction. No statistically significant differences in longitudinal response patterns were detected between the two techniques. The one-point technique may represent a simpler injection approach worthy of further investigation. Thai Clinical Trials Registry: TCTR20251016020 (registered October 16, 2025).

Scientific Reports
Mahidol University (TH)
Botulinum Toxin and Related Neurological Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon